Profound Medical Corp. (PROF)
5.83
-0.22 (-3.64%)
At close: Mar 31, 2025, 12:24 PM
Profound Medical Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Revenue | 10.68M | 7.2M | 6.68M | 6.87M | 7.3M | 4.23M | 1.91M | 3.9M | n/a | n/a | n/a |
| Cost of Revenue | 3.64M | 2.82M | 3.66M | 3.92M | 3.83M | 1.81M | 1.31M | 2.41M | 187.01K | 119.03K | n/a |
| Gross Profit | 7.04M | 4.38M | 3.02M | 2.95M | 3.47M | 2.42M | 604.82K | 1.49M | -187.01K | -119.03K | n/a |
| Operating Income | -33.06M | -28.62M | -29.6M | -30.29M | -18.86M | -15.13M | -14.83M | -17.63M | -15.64M | -11.22M | -4.34M |
| Interest Income | n/a | 1.64M | 803K | 205K | 692K | 368.46K | 355.2K | 101.58K | 117.25K | 99.24K | 8.53K |
| Pretax Income | 27.82M | -28.7M | -28.38M | -30.59M | -21.58M | -15.31M | -15.07M | -14.91M | -12.14M | -12.32M | -7.94M |
| Net Income | -27.82M | -28.57M | -28.67M | -30.7M | -21.62M | -15.46M | -15.24M | -14.97M | -12.15M | -11.8M | -8.2M |
| Selling & General & Admin | 23.13M | 18.62M | 17.93M | 17.97M | 12.43M | 8.01M | 7.89M | 7.84M | 4.2M | 4.39M | 1.95M |
| Research & Development | 16.96M | 14.38M | 14.69M | 15.28M | 9.91M | 9.54M | 7.54M | 7.66M | 7.43M | 3.7M | 2.31M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 3.76K | 3.65K | 1.57K | 0.00 | 82.4K |
| Operating Expenses | 40.1M | 33M | 32.62M | 33.24M | 22.34M | 17.56M | 15.43M | 15.51M | 11.64M | 8.09M | 4.34M |
| Interest Expense | n/a | 932.8K | 174K | 303K | 543K | 544.75K | 755.37K | 1.07M | 615.87K | 4.05M | 143.01K |
| Selling & Marketing Expenses | n/a | 9.45M | 8.47M | 7.65M | 4.86M | 2.14M | 3M | 3.12M | n/a | n/a | n/a |
| Cost & Expenses | 43.74M | 35.81M | 36.28M | 37.16M | 26.17M | 19.36M | 16.74M | 17.92M | 11.64M | 8.09M | 4.34M |
| Income Tax | -2K | -128K | 287K | 105K | 45K | 148.42K | 169.44K | 58.94K | 10.46K | -523.22K | 410.41K |
| Shares Outstanding (Basic) | 24.77M | 21.18M | 20.77M | 20.46M | 17.29M | 11.09M | 10.04M | 6.14M | 4.15M | 2.37M | 216.68K |
| Shares Outstanding (Diluted) | 24.77M | 21.18M | 20.77M | 20.47M | 17.29M | 11.09M | 10.04M | 6.14M | 4.15M | 2.37M | 216.68K |
| EPS (Basic) | 1.12 | -1.35 | -1.38 | -1.5 | -1.25 | -1.39 | -1.52 | -2.44 | -2.93 | -4.98 | -37.86 |
| EPS (Diluted) | 1.12 | -1.35 | -1.38 | -1.5 | -1.25 | -1.39 | -1.52 | -2.44 | -2.93 | -4.98 | -37.86 |
| EBITDA | -33.06M | -26.78M | -34.63M | -28.65M | -19.5M | -12.53M | -13.24M | -16.78M | -15.56M | -11.15M | -6.31M |
| Depreciation & Amortization | n/a | 1.15M | 2.09M | 2.36M | 2.06M | 2.01M | 1.68M | 876.42K | 187.01K | 85.77K | 84.9K |